Clinical Trial

A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of bronchoscopic airway clearance and amphotericin B spraying in the treatment of allergic bronchopulmonary aspergillosis
Trial Details
NCT Number NCT07362667
Lead Sponsor Qianfoshan Hospital
Conditions ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA), Airway Clearance, Mucus Plug, Amphotericin B, Bronchoscope
Enrollment 44 participants
Start Date 2026-01-10
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23